Correlation of a vancomycin pharmacokinetic model and trough serum concentrations in pediatric patients

Cady Ploessl, Christopher White, Kalen Manasco

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Vancomycin trough concentrations specific to pediatric patients have yet to be validated that achieve an area under the curve (AUC) over 24 hours to minimum inhibitory concentration (MIC) ratio ≥400. The primary objective of this study was to validate a pharmacokinetic model in a pediatric hospital and determine the correlation between a calculated AUC/MIC ratio and measured trough vancomycin concentration. Methods: A retrospective evaluation of patients aged 3 months to 18 years prescribed vancomycin at a pediatric hospital between January 2012 and June 2013. The correlation between patient-specific AUC/MIC and measured vancomycin trough concentration was assessed. Results: Forty pediatric patients with 40 vancomycin trough concentrations and documented Staphylococcus aureus cultures were included in the study. Median age was 8.5 (interquartile range, 2.14.3) years, median weight 28.7 (range, 14.50.2) kg, and mean baseline serum creatinine 0.51 ± 0.3 mg/dL. The mean daily dose of vancomycin prescribed was 58 ± 13.8 mg/kg/d. The mean vancomycin trough concentration was 11 ± 5.5 mcg/mL, and the mean AUC/MIC was 534 ± 373. No correlation was found between trough concentration and AUC/MIC (r<sup>2</sup> = 0.082, p = 0.07). Conclusions: This study validates the clinical applicability of a pharmacokinetic model for calculating vancomycin clearance to determine patientspecific AUC over 24 hours in pediatrics. Trough concentrations associated with proposed therapeutic AUC/MIC ratios were lower than reported in the adult population. Further research is needed to determine if AUC/MIC, trough concentration, or both is best for monitoring therapeutic efficacy of vancomycin in pediatrics.

Original languageEnglish (US)
Pages (from-to)e244-e247
JournalPediatric Infectious Disease Journal
Volume34
Issue number10
DOIs
StatePublished - Oct 1 2015

Fingerprint

Vancomycin
Microbial Sensitivity Tests
Area Under Curve
Pharmacokinetics
Pediatrics
Serum
Pediatric Hospitals
Staphylococcus aureus
Creatinine
Weights and Measures
Therapeutics
Research

Keywords

  • Area under the curve
  • Pediatrics
  • Staphylococcus aureus
  • Vancomycin

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Infectious Diseases
  • Microbiology (medical)

Cite this

Correlation of a vancomycin pharmacokinetic model and trough serum concentrations in pediatric patients. / Ploessl, Cady; White, Christopher; Manasco, Kalen.

In: Pediatric Infectious Disease Journal, Vol. 34, No. 10, 01.10.2015, p. e244-e247.

Research output: Contribution to journalArticle

Ploessl, Cady ; White, Christopher ; Manasco, Kalen. / Correlation of a vancomycin pharmacokinetic model and trough serum concentrations in pediatric patients. In: Pediatric Infectious Disease Journal. 2015 ; Vol. 34, No. 10. pp. e244-e247.
@article{48fd40093dfa452580b5f12833e7a0e8,
title = "Correlation of a vancomycin pharmacokinetic model and trough serum concentrations in pediatric patients",
abstract = "Background: Vancomycin trough concentrations specific to pediatric patients have yet to be validated that achieve an area under the curve (AUC) over 24 hours to minimum inhibitory concentration (MIC) ratio ≥400. The primary objective of this study was to validate a pharmacokinetic model in a pediatric hospital and determine the correlation between a calculated AUC/MIC ratio and measured trough vancomycin concentration. Methods: A retrospective evaluation of patients aged 3 months to 18 years prescribed vancomycin at a pediatric hospital between January 2012 and June 2013. The correlation between patient-specific AUC/MIC and measured vancomycin trough concentration was assessed. Results: Forty pediatric patients with 40 vancomycin trough concentrations and documented Staphylococcus aureus cultures were included in the study. Median age was 8.5 (interquartile range, 2.14.3) years, median weight 28.7 (range, 14.50.2) kg, and mean baseline serum creatinine 0.51 ± 0.3 mg/dL. The mean daily dose of vancomycin prescribed was 58 ± 13.8 mg/kg/d. The mean vancomycin trough concentration was 11 ± 5.5 mcg/mL, and the mean AUC/MIC was 534 ± 373. No correlation was found between trough concentration and AUC/MIC (r2 = 0.082, p = 0.07). Conclusions: This study validates the clinical applicability of a pharmacokinetic model for calculating vancomycin clearance to determine patientspecific AUC over 24 hours in pediatrics. Trough concentrations associated with proposed therapeutic AUC/MIC ratios were lower than reported in the adult population. Further research is needed to determine if AUC/MIC, trough concentration, or both is best for monitoring therapeutic efficacy of vancomycin in pediatrics.",
keywords = "Area under the curve, Pediatrics, Staphylococcus aureus, Vancomycin",
author = "Cady Ploessl and Christopher White and Kalen Manasco",
year = "2015",
month = "10",
day = "1",
doi = "10.1097/INF.0000000000000817",
language = "English (US)",
volume = "34",
pages = "e244--e247",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Correlation of a vancomycin pharmacokinetic model and trough serum concentrations in pediatric patients

AU - Ploessl, Cady

AU - White, Christopher

AU - Manasco, Kalen

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background: Vancomycin trough concentrations specific to pediatric patients have yet to be validated that achieve an area under the curve (AUC) over 24 hours to minimum inhibitory concentration (MIC) ratio ≥400. The primary objective of this study was to validate a pharmacokinetic model in a pediatric hospital and determine the correlation between a calculated AUC/MIC ratio and measured trough vancomycin concentration. Methods: A retrospective evaluation of patients aged 3 months to 18 years prescribed vancomycin at a pediatric hospital between January 2012 and June 2013. The correlation between patient-specific AUC/MIC and measured vancomycin trough concentration was assessed. Results: Forty pediatric patients with 40 vancomycin trough concentrations and documented Staphylococcus aureus cultures were included in the study. Median age was 8.5 (interquartile range, 2.14.3) years, median weight 28.7 (range, 14.50.2) kg, and mean baseline serum creatinine 0.51 ± 0.3 mg/dL. The mean daily dose of vancomycin prescribed was 58 ± 13.8 mg/kg/d. The mean vancomycin trough concentration was 11 ± 5.5 mcg/mL, and the mean AUC/MIC was 534 ± 373. No correlation was found between trough concentration and AUC/MIC (r2 = 0.082, p = 0.07). Conclusions: This study validates the clinical applicability of a pharmacokinetic model for calculating vancomycin clearance to determine patientspecific AUC over 24 hours in pediatrics. Trough concentrations associated with proposed therapeutic AUC/MIC ratios were lower than reported in the adult population. Further research is needed to determine if AUC/MIC, trough concentration, or both is best for monitoring therapeutic efficacy of vancomycin in pediatrics.

AB - Background: Vancomycin trough concentrations specific to pediatric patients have yet to be validated that achieve an area under the curve (AUC) over 24 hours to minimum inhibitory concentration (MIC) ratio ≥400. The primary objective of this study was to validate a pharmacokinetic model in a pediatric hospital and determine the correlation between a calculated AUC/MIC ratio and measured trough vancomycin concentration. Methods: A retrospective evaluation of patients aged 3 months to 18 years prescribed vancomycin at a pediatric hospital between January 2012 and June 2013. The correlation between patient-specific AUC/MIC and measured vancomycin trough concentration was assessed. Results: Forty pediatric patients with 40 vancomycin trough concentrations and documented Staphylococcus aureus cultures were included in the study. Median age was 8.5 (interquartile range, 2.14.3) years, median weight 28.7 (range, 14.50.2) kg, and mean baseline serum creatinine 0.51 ± 0.3 mg/dL. The mean daily dose of vancomycin prescribed was 58 ± 13.8 mg/kg/d. The mean vancomycin trough concentration was 11 ± 5.5 mcg/mL, and the mean AUC/MIC was 534 ± 373. No correlation was found between trough concentration and AUC/MIC (r2 = 0.082, p = 0.07). Conclusions: This study validates the clinical applicability of a pharmacokinetic model for calculating vancomycin clearance to determine patientspecific AUC over 24 hours in pediatrics. Trough concentrations associated with proposed therapeutic AUC/MIC ratios were lower than reported in the adult population. Further research is needed to determine if AUC/MIC, trough concentration, or both is best for monitoring therapeutic efficacy of vancomycin in pediatrics.

KW - Area under the curve

KW - Pediatrics

KW - Staphylococcus aureus

KW - Vancomycin

UR - http://www.scopus.com/inward/record.url?scp=84942010562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942010562&partnerID=8YFLogxK

U2 - 10.1097/INF.0000000000000817

DO - 10.1097/INF.0000000000000817

M3 - Article

VL - 34

SP - e244-e247

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 10

ER -